Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 2/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | PIK3R5 | Q8WYR1 | 1/20 | 0.40 |
| ▸ | PIK3R3 | Q92569 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12449601 | 0.86 | SIGMAR1 (0.58) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL11596 | 0.85 | SIGMAR1 (0.45) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL12221 | 0.85 | MEN1 (0.47) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL201588 | 0.83 | SHBG (0.46) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL14321356 | 0.83 | CD274 (0.45) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL12449799 | 0.78 | SIGMAR1 (0.40) | SIGMAR1GAAMEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL11186064 | 0.78 | HPGD (0.54) | GAAMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL201656 | 0.76 | GAA (0.39) | SIGMAR1GAALMNASMN1; SMN2RAB9A | |
| SCHEMBL12276222 | 0.76 | LMNA (0.42) | SIGMAR1GAAMEN1KMT2ALMNA | |
| SCHEMBL12677 | 0.72 | F10 (0.41) | MEN1KMT2ALMNAF10PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088922-B2 | Dibenzorylenetetracarboximides as infrared absorbers | BASF AKTIENGESELLSCHAFT (DE) | 2012-01-03 | — | — | US | disclosed |
| EP-2029573-B1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2011-10-26 | — | — | EP | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| US-7408061-B2 | Rylene dyes | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-05 | — | — | US | disclosed |
| EP-1521815-B1 | COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING | BASF SE (DE) | 2008-07-16 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| US-7252785-B2 | Composition of a radiation-absorbing tert-alkylphenoxy-substituted polycyclic ccmpound and a curable IR-reflecting component of achiral nematic polymerizable monomer, a chiral polymerizable monomer, a cholesteric polymerizable monomer, and a cholesteric polymer in a polymerizable diluent | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-07 | — | — | US | disclosed |
| US-7145010-B2 | Tert-alkylphenoxy-substituted polycyclic compounds | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-05 | — | — | US | disclosed |
| EP-1532210-B1 | RYLENE DYES | BASF AG (DE) | 2006-11-22 | — | — | EP | disclosed |
| EP-1532210-A1 | RYLENE DYES | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-25 | — | — | EP | disclosed |
| EP-1521815-A2 | COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-13 | — | — | EP | disclosed |
| EP-1379577-B1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA INC (US) | 2004-08-25 | — | — | EP | disclosed |
| US-6737159-B2 | Controlling solar radiation in safety glass laminates | SOLUTIA, INC. | 2004-05-18 | — | — | US | disclosed |
| WO-2004026965-A1 | RYLENE DYES | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-01 | — | — | WO | disclosed |
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | BASF SE (DE) | 2004-03-11 | — | — | US | disclosed |
| WO-2004005427-A2 | COMPOSITION FOR PRODUCING A THERMAL INSULATION COATING | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-15 | — | — | WO | disclosed |
| EP-1379577-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | Solutia Inc. (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20020182422-A1 | Controlling solar radiation in safety glass laminates | SOLUTIA INC. | 2002-12-05 | — | — | US | disclosed |
| WO-2002077081-A1 | CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES | SOLUTIA, INC. (US) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | SIGMAR1 4155/4885GAA 4647/4885MEN1 355/4885 |
| US-20040049030-A1 | Tert alkylphenoxy substituted polycyclic compounds | NR3C1, NR1H4, NR5A1 | SIGMAR1 102/4885GAA 4598/4885MEN1 1779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.